Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Rosenblatt raised the price target for Fabrinet FN from $260 to $280. Rosenblatt analyst Mike Genovese maintained a Buy rating. Fabrinet shares gained 0.2% to close at $231.55 on Monday. See how other analysts view this stock.
- Telsey Advisory Group cut the price target for The Estée Lauder Companies Inc. EL from $115 to $105. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. Estée Lauder shares fell 2.2% to close at $92.85 on Monday. See how other analysts view this stock.
- B of A Securities cut Liquidia Corporation LQDA price target from $24 to $23. B of A Securities analyst Greg Harrison maintained a Buy rating. Liquidia shares dipped 30.6% to close at $9.79 on Monday. See how other analysts view this stock.
- Keybanc boosted the price target for Palo Alto Networks, Inc. PANW from $380 to $400. Keybanc analyst Eric Heath maintained an Overweight rating. Palo Alto shares gained 2.8% to close at $343.36 on Monday. See how other analysts view this stock.
- Baird slashed Snowflake Inc. SNOW price target from $200 to $165. Baird analyst William Power maintained an Outperform rating. Snowflake shares gained 2.6% to close at $131.42 on Monday. See how other analysts view this stock.
- Jefferies raised ZIM Integrated Shipping Services Ltd. ZIM price target from $22 to $25. Jefferies analyst Omar Nokta maintained a Buy rating. ZIM Integrated Shipping shares gained 16.7% to close at $22.25 on Monday. See how other analysts view this stock.
- UBS increased the price target for Globant S.A. GLOB from $225 to $235. UBS analyst Leonardo Olmos downgraded the stock from Buy to Neutral. Globant shares fell 1.1% to close at $201.98 on Monday. See how other analysts view this stock.
- Citigroup boosted Stride, Inc. LRN price target from $77 to $90. Citigroup analyst Thomas Singlehurst downgraded the stock from Buy to Neutral. Stride shares gained 1.5% to close at $83.77 on Monday. See how other analysts view this stock.
- Bernstein boosted BioMarin Pharmaceutical Inc. BMRN price target from $94 to $110. Bernstein analyst William Pickering upgraded the stock from Market Perform to Outperform. BioMarin Pharmaceutical shares gained 3.6% to close at $92.76 on Monday. See how other analysts view this stock.
- Stifel raised Hyatt Hotels Corporation H price target from $141 to $151. Stifel analyst Simon Yarmak maintained a Hold rating. Hyatt shares gained 2.5% to close at $146.67 on Monday. See how other analysts view this stock.
Considering buying Robinhood stock? Here’s what analysts think:
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20075209/image-164-1024x595.png)
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: NewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalyst forecastsPT Changes
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in